Emerging Biopharma

Stethoscope and red heart with pink background
Biotech

US VC launches another biotech with China-licensed asset

Aditum is offering up to $1 billion biobucks to Mabwell for exclusive global licensing rights to a dual-target siRNA candidate.
Gabrielle Masson Sep 17, 2025 10:30am
start line beginning road path starting point journey

Pfizer vet takes CEO post at new, phase 3-ready biotech

Sep 9, 2025 10:03am
heart over ekg

Corsera launches with $50M for predictive AI tool, RNAi asset

Sep 2, 2025 6:30am
RNA Concept 3D Render

RNA biotech emerges with $52M and clinical rare disease asset

Aug 25, 2025 10:13am
Basel Switzerland

Is Basel the next Boston? The Swiss biotech hub raising its game

Aug 8, 2025 9:50am
coins money pennies cents

Charles River explores crowdfunding for cell and gene incubator

Aug 4, 2025 2:55pm
More News

OrbiMed gets $1.86B for latest fund despite 'challenging' market

Aug 4, 2025 10:25am

Frazier Life Sciences raises $1.3B for early-stage biotech fund

Jul 31, 2025 7:54am

BMS hands 5 autoimmune drugs to Bain-backed spinout

Jul 29, 2025 5:08am

BMS-backed Dispatch unveils with $216M, Carl June as cofounder

Jul 23, 2025 6:30am